Evidence map›Paper›PMID 33757300›Full record

ArticleStem cells and development2021

Deepanwita Pal, Scott M Riester, Bashar Hasan, Sara F Tufa, Amel Dudakovic, Douglas R Keene, Andre J van Wijnen, Ronen Schweitzer

Open access · greenAbstract read
In one paragraph

Article in Stem cells and development, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Deepanwita PalResearch Division, Shriners Hospital for Children, Portland, Oregon, USA.
Scott M RiesterDepartment of Orthopedic Surgery, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Bashar HasanDepartment of Orthopedic Surgery, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Sara F TufaResearch Division, Shriners Hospital for Children, Portland, Oregon, USA.
Amel DudakovicDepartment of Orthopedic Surgery, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Douglas R KeeneResearch Division, Shriners Hospital for Children, Portland, Oregon, USA.
Andre J van WijnenDepartment of Orthopedic Surgery, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-4458-0946
Ronen SchweitzerResearch Division, Shriners Hospital for Children, Portland, Oregon, USA.
Mayo Clinic · USOregon Health & Science University · USShriners Hospitals for Children - Portland · US

Funding

Experimental Resources for Studies of Tenocyte Differentiation and Cell Fate DiversityR01AR072716 · NIAMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI SCHWEITZER, RONEN · 2018 to 2022
$1.7M
Maintenance and Regulation of Tendon and Ligament Maturation by TGFbeta SignalingR01AR067211 · NIAMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI SCHWEITZER, RONEN · 2016 to 2020
$1.5M
NIAMS NIH HHS R01 AR067211NIAMS NIH HHS R01 AR072716
6 · The paper itself

Abstract

An efficient musculoskeletal system depends on the precise assembly and coordinated growth and function of muscles, skeleton, and tendons. However, the mechanisms that drive integrated musculoskeletal development and coordinated growth and differentiation of each of these tissues are still being uncovered. Epigenetic modifiers have emerged as critical regulators of cell fate differentiation, but so far almost nothing is known about their roles in tendon biology. Previous studies have shown that epigenetic modifications driven by Enhancer of zeste homolog 2 (EZH2), a major histone methyltransferase, have significant roles in vertebrate development including skeletal patterning and bone formation. We now find that targeting

Indexed as

Enhancer of Zeste Homolog 2 ProteinOsteogenesisCell DifferentiationMesodermTendonsEnhancer of Zeste Homolog 2 ProteinepigeneticsEzh2musculoskeletalpatterningtendon

Identifiers

PMID33757300
PMCPMC8165461
OpenAlexW3137609783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.